MedPath

A Feasibility Study to Improve Colorectal Cancer Screening Among Racially Diverse Zip Codes in a Persistent Poverty County Using Navigation and Machine Learning Predictive Algorithms

Completed
Conditions
Colorectal Cancer
Interventions
Other: Machine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation Program
Registration Number
NCT05383976
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Brief Summary

The overarching goals of the "PCSNaP" Research Study is to support the Abramson Cancer Center (ACC) of the University of Pennsylvania in carrying out its mission to increase colorectal cancer (CRC) screening completion among high-risk individuals living in a persistent poverty county by designing, conducting, disseminating and evaluating an electronic health record-based automated identification program to target effective, culturally-sensitive CRC screening navigation to individuals who have not completed an ordered colonoscopy or fecal immunochemical test (FIT).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
201
Inclusion Criteria
  • Patients residing in 18 zip codes in Western and Southwestern Philadelphia who have primary care providers in 4 Penn Medicine Internal Medicine practices and 3 Penn Medicine Family Medicine Practices
  • Patients who have had a colonoscopy order placed in the past 6 months and have not scheduled, cancelled, or no-showed to their colonoscopy
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients Residing in 18 zip codes in Western and Southwestern PhiladelphiaMachine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation ProgramThe cohort will consist of patients residing in 18 zip codes in Western and Southwestern Philadelphia who have primary care providers in 4 Penn Medicine Internal Medicine practices and 3 Penn Medicine Family Medicine Practices.
Primary Outcome Measures
NameTimeMethod
Enrollment in Navigator Program (Feasibility)During the three month enrollment period

Number of patients that participate in the navigation program

Completion of Colorectal Cancer ScreeningWithin the three month enrollment period and three month follow-up period

Number of patients that have completed their colonoscopy or FIT

Adenoma Detection RateWithin the three month enrollment period and three month follow-up period

Rate of adenomas after completion of colonoscopy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath